NIH-funded research NIH-funded research

Transplanting brain cells to treat severe epilepsy

Official title: Cortical Interneuron Transplantation to Treat Intractable Epilepsy

Funded at Rutgers Biomedical and Health Sciences · NIH-10782798 · Data updated 2026-11-12

This study is exploring a new way to help people with hard-to-treat epilepsy by transplanting special brain cells into their brains, which might help reduce seizures and improve their daily lives.

More Epilepsy research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startSeptember 7, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$666,380
NIH project number1UG3NS129630-01A1
Project IDNIH-10782798 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 21 and older who suffer from intractable epilepsy and have not found relief from anti-seizure medications.

Less likely to help

Patients whose seizures are well-controlled with current anti-seizure medications may not benefit from this research.

What this research studies

This research investigates a novel approach to treating intractable epilepsy by transplanting specialized brain cells called cortical interneurons into the brains of patients. The goal is to enhance the brain's ability to inhibit abnormal electrical activity that leads to seizures. By using human pluripotent stem cells to create these neurons, the study aims to overcome ethical concerns associated with fetal neuron use and ensure safe integration into the brain's circuitry. Patients participating in this research may receive these transplanted cells to potentially reduce their seizure frequency and improve their quality of life.

Why it matters

Potential benefit: If successful, this research could provide a new therapeutic option for patients with epilepsy who do not respond to existing treatments.

How similar studies have gone: Previous studies have shown promise in using cell transplantation for epilepsy treatment, indicating that this approach could be a viable option.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Chung, Sangmi — Rutgers Biomedical and Health Sciences
  • Study coordinator: Chung, Sangmi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.